Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koistinen, H.
Right arrow Articles by Koistinen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koistinen, H.
Right arrow Articles by Koistinen, R.
Agricola
Right arrow Articles by Koistinen, H.
Right arrow Articles by Koistinen, R.
Biology of Reproduction 66, 624-628 (2002)
© 2002 Society for the Study of Reproduction, Inc.


Regular Article

Monoclonal Antibodies, Immunofluorometric Assay, and Detection of Human Semenogelin in Male Reproductive Tract: No Association with In Vitro Fertilizing Capacity of Sperm1

Hannu Koistinena, Tuuli Soinia, Jari Leinonenb, Christel Hyden-Granskoga, Jaakko Saloc, Mervi Halttunena, Ulf-Håkan Stenmanb, Markku Seppäläa, and Riitta Koistinen2,a

a Departments of Obstetrics and Gynecology, b Clinical Chemistry, c Urology, Helsinki University Central Hospital, 00290 Helsinki, Finland

Semenogelin plays an important role in sperm clotting and is degraded into smaller fragments by prostate-specific antigen (PSA) during clot liquefaction. Semenogelin and its fragments inhibit sperm motility in vitro. We studied the expression of semenogelin I mRNA and its localization in various tissues of the male genital tract. We also studied semenogelin concentrations with respect to sperm parameters and the outcome of in vitro fertilization. Semenogelin protein was detected by immunohistochemical staining and semenogelin I mRNA was detected by Northern blot analysis in the seminal vesicles and ampullary part of the vas deferens, whereas specimens from the prostate, epididymis, testis, and the female genital tract were negative. Using monoclonal antibodies against semenogelin, an immunofluorometric assay was developed to measure semenogelin levels in seminal plasma and to evaluate possible correlations with sperm parameters and fertilization in vitro. No correlation was found between the semenogelin concentration and the volume of the ejaculate, sperm concentration, sperm motility, or in vitro fertilization rate. Semenogelin levels were positively correlated with the total protein concentration in seminal plasma, and there was an inverse correlation between the concentration of semenogelin and that of PSA. The levels of semenogelin appear to bear no relationship to the in vitro fertilization capacity of the spermatozoa.

First decision: 12 June 2001.

1 This study was supported by grants from the Helsinki University Central Hospital Research Funds, the Federation of Finnish Life and Pension Insurance Companies, the Finnish Cancer Foundation, the Academy of Finland, and the University of Helsinki.

2 Correspondence: Riitta Koistinen, Biomedicum Helsinki, Department of Obstetrics and Gynecology, Helsinki University Central Hospital, P.O. Box 700 (Haartmaninkatu 8), 00029 HUS (Helsinki), Finland. FAX: 358 9 471 71731; riitta.koistinen{at}hus.fi




This article has been cited by other articles:


Home page
Cancer Res.Home page
T. Hienonen, H. Sammalkorpi, S. Enholm, P. Alhopuro, T. D. Barber, R. Lehtonen, N. N. Nupponen, H. Lehtonen, R. Salovaara, J.-P. Mecklin, et al.
Mutations in Two Short Noncoding Mononucleotide Repeats in Most Microsatellite-Unstable Colorectal Cancers
Cancer Res., June 1, 2005; 65(11): 4607 - 4613.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
K. Yoshida, T. Yamasaki, M. Yoshiike, S. Takano, I. Sato, and T. Iwamoto
Quantification of Seminal Plasma Motility Inhibitor/Semenogelin in Human Seminal Plasma
J Androl, November 1, 2003; 24(6): 878 - 884.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Lundwall, A. Giwercman, Y. Ruhayel, Y. Giwercman, H. Lilja, C. Hallden, and J. Malm
A frequent allele codes for a truncated variant of semenogelin I, the major protein component of human semen coagulum
Mol. Hum. Reprod., June 1, 2003; 9(6): 345 - 350.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for the Study of Reproduction.